HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emergency Superficial Temporal Artery to Middle Cerebral Artery Bypass After Intravenous Administration of Tissue Plasminogen Activator for Stroke.

Abstract
Intravenous tissue plasminogen activator (IVtPA) is effective for the treatment of acute stroke. Although IVtPA is easily administered and is effective in many cases, the clinical condition of some patients can worsen after the initiation of thrombolytic therapy due to sustained cerebrovascular insufficiency. In such cases, several additional treatment options to re-establish cerebral perfusion are available, including superficial temporal artery to middle cerebral artery bypass. However, it is recommended that invasive procedures should be avoided soon after IVtPA administration because tPA is believed to exert prolonged fibrinolytic effects may continue for more than 24 hours. We described three cases of emergency superficial temporal artery to middle cerebral artery bypass performed within 24 hours of IVtPA administration, and discussed the safety of such procedures. We believe that superficial temporal artery to middle cerebral artery bypass can be safely performed even within 24 hours after IVtPA administration.
AuthorsSatoru Takeuchi, Kojiro Wada, Hirohiko Arimoto, Kosuke Kumagai, Hideo Osada, Naoki Otani, Kentaro Mori
JournalTurkish neurosurgery (Turk Neurosurg) Vol. 25 Issue 4 Pg. 633-7 ( 2015) ISSN: 1019-5149 [Print] Turkey
PMID26242342 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Fibrinolytic Agents
  • Tissue Plasminogen Activator
Topics
  • Aged
  • Cerebrovascular Circulation
  • Female
  • Fibrinolytic Agents (administration & dosage, therapeutic use)
  • Giant Cell Arteritis (surgery)
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Middle Cerebral Artery (surgery)
  • Neurosurgical Procedures (methods)
  • Paresis (etiology, therapy)
  • Stroke (drug therapy, surgery)
  • Thrombolytic Therapy (methods)
  • Tissue Plasminogen Activator (administration & dosage, therapeutic use)
  • Tomography, X-Ray Computed
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: